Intas Pharmaceuticals Ltd — Cisplatin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Cisplatin · $268.6K export value · DGFT Verified
Intas Pharmaceuticals Ltd is the #9 Indian exporter of Cisplatin with $268.6K in export value and 15 verified shipments. Intas Pharmaceuticals Ltd holds a 2.1% market share in Cisplatin exports across 9 countries.
Intas Pharmaceuticals Ltd — Cisplatin Export Profile: Buyers & Destinations
Where Does Intas Pharmaceuticals Ltd Export Cisplatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $237.5K | 23 | 16.8% |
| CANADA | $180.0K | 5 | 12.7% |
| NETHERLANDS | $157.6K | 9 | 11.1% |
| AUSTRALIA | $150.0K | 3 | 10.6% |
| POLAND | $133.3K | 5 | 9.4% |
| UNITED KINGDOM | $108.3K | 5 | 7.7% |
| FRANCE | $100.0K | 2 | 7.1% |
| UNITED STATES OF AMERICA | $100.0K | 2 | 7.1% |
| PHILIPPINES | $91.9K | 6 | 6.5% |
| SOUTH AFRICA | $65.4K | 4 | 4.6% |
Intas Pharmaceuticals Ltd exports Cisplatin to 14 countries. The largest destination is BRAZIL accounting for 16.8% of Intas Pharmaceuticals Ltd's Cisplatin shipments, followed by CANADA (12.7%) and NETHERLANDS (11.1%). These destinations reflect Intas Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cisplatin from Intas Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| XXCORXXHEAXXHCAXX INXX | CANADA | $200.0K | 4 |
| ACCORD FARMACUTICA LTDA. | BRAZIL | $129.0K | 12 |
| ACCORD HEALTHCARE B V | NETHERLANDS | $127.1K | 6 |
| ACCORD HEALTHCARE INC | CANADA | $114.8K | 3 |
| XXCORXXHEAXXHCAXX PTXXLIMITED | AUSTRALIA | $100.0K | 2 |
| ASIA UNITED BANK CORPORATION | PHILIPPINES | $89.3K | 5 |
| ACCORD HEALTHCARE POLSKA SP Z O O | POLAND | $86.6K | 4 |
| XXCORXXHEAXXHCAXX B XX | FRANCE | $74.7K | 2 |
| ACCORD FARMACUTICA LTDA | BRAZIL | $64.6K | 6 |
| XXCORXXHEAXXHCAXX LTXX | UNITED KINGDOM | $61.0K | 9 |
Intas Pharmaceuticals Ltd supplies Cisplatin to 29 buyers globally. The largest buyer is XXCORXXHEAXXHCAXX INXX (CANADA), followed by ACCORD FARMACUTICA LTDA. (BRAZIL) and ACCORD HEALTHCARE B V (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cisplatin Export Value and How Much Does Intas Pharmaceuticals Ltd Contribute?
India exported $9.6M worth of Cisplatin through 1,701 shipments from 233 suppliers to 130 countries, serving 584 buyers globally. Intas Pharmaceuticals Ltd contributes $268.6K to this total, accounting for 2.1% of India's Cisplatin exports. Intas Pharmaceuticals Ltd ships Cisplatin to 14 countries through 29 buyers.
What Is the Average Shipment Value for Intas Pharmaceuticals Ltd's Cisplatin Exports?
Intas Pharmaceuticals Ltd's average Cisplatin shipment value is $17.9K per consignment, based on 15 shipments totaling $268.6K. The largest destination is BRAZIL (16.8% of Intas Pharmaceuticals Ltd's Cisplatin exports).
How Does Intas Pharmaceuticals Ltd Compare to Other Indian Cisplatin Exporters?
Intas Pharmaceuticals Ltd ranks #9 among 233 Indian Cisplatin exporters with a 2.1% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($2.8M), VENUS REMEDIES LIMITED ($1.7M), INTAS PHARMACEUTICALS LIMITED ($1.5M). Intas Pharmaceuticals Ltd processed 15 shipments to 9 destination countries.
What Cisplatin Formulations Does Intas Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CISPLATIN INJ 1 MG/ML 100 ML | $152.6K | 5 |
| PHARMA DRUGS & MEDI CISPLATIN INJ BP 1MG | $137.4K | 13 |
| CISPLATIN INJECTION BP-1MG/ML(100MG/100M | $100.0K | 2 |
| CISPLATIN ACC INJ 100MG/100ML 1V(ACC-AUS | $100.0K | 2 |
| PHARMA DRUG&MED:PLATIN-Cisplatin 1mg/ml, | $53.2K | 2 |
| CISPLATIN 1MG/ML 100ML P1 ACO-FRANCE | $50.0K | 2 |
| CISPLATIN 1MG/ML 100ML P1 (ACO-FRANCE | $50.0K | 1 |
| CISPLATIN ACC INJ 100MG/100ML 1VACC-AUS | $50.0K | 1 |
| CISPLATIN INJECTION BP-1MG/ML100MG/100M | $50.0K | 1 |
| CISPLATIN 1MG/ML 100ML P1(ACO-POLAND | $46.7K | 2 |
Intas Pharmaceuticals Ltd exports 48 distinct Cisplatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CISPLATIN INJ 1 MG/ML 100 ML with 5 shipments worth $152.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Cisplatin to Key Markets
What Intas Pharmaceuticals Ltd must comply with to export Cisplatin to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Intas Pharmaceuticals Ltd Compare to Nearest Cisplatin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $507.6K | 29 | 8 | $17.5K |
| 8 | UNITED BIOTECH PRIVATE LIMITED | $489.4K | 97 | 14 | $5.0K |
| 9 | INTAS PHARMACEUTICALS LTD ★ | $268.6K | 15 | 9 | $17.9K |
| 10 | SP ACCURE LABS PRIVATE LIMITED | $233.8K | 27 | 9 | $8.7K |
| 11 | MEDORBIS TRADE LLP | $208.8K | 11 | 2 | $19.0K |
Intas Pharmaceuticals Ltd ranks #9 among 233 Indian Cisplatin exporters. Average shipment value of $17.9K compared to the market average of $41.2K. The closest competitors by value are NAPROD LIFE SCIENCES PRIVATE LIMITED and UNITED BIOTECH PRIVATE LIMITED.
Which Indian Ports Ship Cisplatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 300 | 17.6% |
| SAHAR AIR | 281 | 16.5% |
| DELHI AIR CARGO ACC (INDEL4) | 260 | 15.3% |
| DELHI AIR | 237 | 13.9% |
| Bombay Air | 104 | 6.1% |
| Delhi Air | 53 | 3.1% |
| Delhi Air Cargo | 37 | 2.2% |
| HYDERABAD ACC (INHYD4) | 35 | 2.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cisplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cisplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Intas Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 88 individual customs records matching Intas Pharmaceuticals Ltd exporting Cisplatin, covering 48 formulations to 14 countries via 29 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 130+ countries, 584+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cisplatin Export Data from Intas Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Intas Pharmaceuticals Ltd's Cisplatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Intas Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Cisplatin Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Intas Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cisplatin. For current shipment-level data, contact TransData Nexus.